0.89% -0.19

Catalyst Pharmaceuticals Inc (CPRX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CPRX? Forum Prognose

Finanzdaten der Catalyst Pharmaceuticals Inc-Aktie (CPRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.91% 98.51	110.57	102.69	99.58	85.37
Cost Of Revenue	20.80% 12.52	15.81	14.17	12.04	9.946
Gross Profit	9.26% 85.99	94.76	88.52	87.54	75.42
Operating Expenses	10.92% 58.86	53.07	125.71	40.84	39.81
Benefits Costs and Expenses	8.70% 69.42	63.86	140.71	51.07	48.05
Costs And Expenses	8.70% 69.42	63.86	140.71	51.07	48.05
Operating Income/Loss	34.94% 27.13	41.69	-37.19	46.70	35.61
Income/Loss From Continuing Operations Before Tax	37.72% 29.09	46.71	-38.02	48.51	37.31
Income Tax Expense/Benefit	50.99% 5.814	11.86	-7.257	10.75	7.745
Income/Loss From Continuing Operations After Tax	33.20% 23.27	34.84	-30.76	37.76	29.57
Net Income/Loss	33.20% 23.27	34.84	-30.76	37.76	29.57
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	79,545% 116.81	0.1467	106.57	106.26	105.56
Diluted Average Shares	6.92M% 123.40	0.00178	106.57	113.67	113.99
Basic Earnings Per Share	39.39% 0.20	0.33	-0.29	0.36	0.28
Diluted Earnings Per Share	38.71% 0.19	0.31	-0.29	0.33	0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%